Close Menu

In this week's Nature Neuroscience, a team of British and Chinese scientists reports on the use of genome-wide association studies to identify existing drugs that may be effective for new indications in psychiatry. By comparing transcriptomes imputed from GWAS data with drug-induced gene expression profiles from the Broad Institute's Connectivity Map cellular signal database, the researchers were able to identify drug candidates for repositioning for seven psychiatric disorders.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.